What is WuXi AppTec?
WuXi AppTec Co., Ltd. is a global investment holding company that provides comprehensive research, development, and manufacturing services for small molecule drugs and advanced therapies. Operating across China, the United States, and Europe, the company's extensive service portfolio spans WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, and WuXi DDSU. They offer end-to-end solutions from drug discovery to commercialization, supporting a wide array of synthetic molecular modalities including small molecules, oligonucleotides, peptides, and complex conjugates. Their biology services are crucial for projects ranging from target discovery to clinical progression, positioning WuXi AppTec as a key enabler in the global pharmaceutical innovation ecosystem.
How much funding has WuXi AppTec raised?
WuXi AppTec has raised a total of $2.2B across 3 funding rounds:
Stock Offering
$184.6M
Debt
$1.5B
Other Financing Round
$500M
Stock Issuance/Offering (2007): $184.6M, investors not publicly disclosed
Debt (2016): $1.5B led by Ping An Bank
Other Financing Round (2024): $500M, investors not publicly disclosed
Key Investors in WuXi AppTec
Ping An Bank
Ping An Bank, part of the broader Ping An Insurance Group, is a major financial institution in China specializing in insurance, banking, and investment banking. Their involvement suggests a strategic financial backing for WuXi AppTec's large-scale operations and growth initiatives.
What's next for WuXi AppTec?
The substantial enterprise-level funding and recent strategic investment indicate WuXi AppTec is in a significant growth phase, likely focused on scaling its advanced therapy capabilities and expanding its global footprint. This capital infusion is expected to bolster its research and manufacturing infrastructure, enabling the company to meet the increasing demand for integrated drug development services. WuXi AppTec's strategic positioning suggests a continued emphasis on innovation and operational excellence to maintain its leadership in the contract research, development, and manufacturing organization (CRDMO) market.
See full WuXi AppTec company page
